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Hemodynamic evaluation of foot venous 
compression devices 
Michael A. Ricci, MD,  RVT,  Peter Fisk, BA, Steven Knight,  BS, RVT,  and 
Terrance Case, MEd,  RVT,  Burlington, Vt. 
Purpose: Venous compression devices effectively prevent deep venous thrombosis. Re- 
cently, because tratunatic injury of the limb often precludes application of calf devices, 
newer methods have been developed that are only applied to the foot. This study was 
designed to evaluate the venous hemodynamic effects produced by four different com- 
pressive devices compared with calf-only intermittent pneumatic compression (IPC). 
Methods: Twenty-seven healthy volunteers had application of each device followed by 
duplex scanning determination of the venous hemodynamics at the popliteal vein (PV) 
and the common femoral vein (CFV). Endpoints included (1) resting (peak) systolic 
velocity (RSV); (2) maximum venous velocity (MVV) during device activation; (3) 
acceleration, the slope of the line from RSV to MVV; and (4) return time (RT) from 
MVV back to RSV. The devices evaluated included two commercially available mechani- 
cal foot devices, (1) foot compressive device (FCD1), and (2) FCD2; (3) an experimental 
mechanical foot device (FCD3); (4) an experimental pneumatic foot device (FCD4); and 
(5) a calf-only IPC device (IPC). 
Results: The RSV was higher in the CFV than the PV. The initial RSV was not statistically 
significant between the five experimental groups (p = 0.37) at either the PV or CFV, 
although the RSV was higher in the CFV than in the calf (CFV, 24.3 -+ 6.7 cm/sec; I'V, 
12.5 - 3.7 cm/sec; p < 0.0001). MVV was significantly higher with FCD2 and the IPC 
(p = 0.0002) at the PV level, but this difference decreased at the CFV. Acceleration was 
greatest with the two available foot devices, FCD1 and FCD2, compared with e other 
three devices (p < 0.0001) at both levels. On the other hand, the RT was significantly 
longer only with the IPC; RT was four to 10 times slower at the PV and three to five 
times slower at the CFV compared with the other four devices. 
Conclusions: The two commercially available foot devices, FCD1 and FCD2, and the IPC 
produced significant alterations in venous hemodynamics. Changes produced at the PV 
level by both foot and calf devices were seen proximally at the CFV, although the changes 
were usually less. The mechanical devices produced rapid acceleration of venous flow to 
an elevated MVV, whereas the IPC produced an elevated peak with a sustained period of 
flow above baseline (RT). Further cliuical comparison should be completed before 
widespread adaptation of these devices as an equivalent to existing IPC devices. (J Vase 
Surg 1997;26:803-8.) 
Intermittent pneumatic ompression (IPC) has 
been proven to be a safe and effective method for 
prophylaxis of deep venous thrombosis (DVT). 1-4 
However, major trauma often precludes the applica- 
tion of devices to the calf and thigh, and pharmaco- 
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logic prophylaxis may also be contraindicated. 4 To 
accommodate this patient group, new devices that 
may be applied only to the foot have been devel- 
oped. 5-9 
The foot has a unique venous tructure and phys- 
iologic mechanism3 °-12 Unlike the rest of  the limb, 
blood flows from the deep veins to the superficial 
veins. When bearing weight, the plantar plexus of the 
foot stretches, forcing blood in the foot into the deep 
veins of the calf as well as the long and short saphe- 
nous veins, without any muscular action.l° The force 
of beating weight, itself, assists in this mechanism. 12
These forces are strong enough to overcome an ex- 
ternal pneumatic alf cuff inflated to 100 mm Hg. n 
Valves within the deep plantar system direct the flow 
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of blood into the deep veins. 12 This physiologic foot 
pump is the basis for venous prophylaxis devices that 
attempt to simulate the force of weight bearing on 
the plantar plexus. 
The present study was designed to evaluate the 
venous hemodynamic changes produced by four dif- 
ferent compressive devices compared with a com- 
monly used calf IPC device. Our hypothesis was that 
calf-only devices would produce more pronounced 
alterations in the venous hemodynamics. 
METHODS 
The use of human subjects in this experiment was 
approved by the University of Vermont Committee 
on Human Research. Twenty-seven healthy volun- 
teers less than 40 years of age with no evidence of 
venous disease were used in this study. 13 
This experiment compared four different foot de- 
vices and a commercially available calf compression 
device: (1) FCD1, A-V Impulse system (Kendall Co., 
Mansfield, Mass.); (2) FCD2, HexiPulse system 
(Model 30010A, Kinetic Conceptions, Inc., San An- 
tonio, Tex.); (3) FCD3, experimental mechanical 
foot device (Advanced Instruments, Norwood, 
Mass.); (4) FCD4, experimental pneumatic foot de- 
vice (Advanced Instruments); and (5) IPC, Veno- 
dyne calf compression device (Model S 10, Advanced 
Instruments; Table I). 
The A-V Impulse System (FCD1) involves a 
pump attached to a rigid foot pad (ImPad Rigid Sole 
Foot Cover). The foot pads are normally fitted to 
both the right and left feet and are available in a 
variety of sizes. The A-V Impulse system provides up 
to a 3-second impulse time, 0.50 to 3.5 seconds 
inflation time, and a pressure range from 50 to 200 
mm Hg. Approximately three cycles per minute are 
delivered. For the purposes of this experiment, a 
0.2S-second impulse time, 3.S-second inflation time 
(total inflation time, 3.75 seconds), and 130 mm Hg 
inflation pressure were used. 
The PlexiPulse foot pump (FCD2) is set up sim- 
ilar to the A-V Impulse. A sleeve wraps around the 
center of the arch secured by Velcro. The cycle time 
can vary from 10 to 60 seconds, and the pressure can 
range from 140 to 180 mm Hg. The standard setting 
is 160 mm Hg, with a hold time of 2 seconds, 
followed by a 20-second rest period. Those settings 
were used in this experiment. 
The first experimental device, FCD3, is a cylin- 
drical cuff designed to fit in the arch of the foot 
similar to a sphygmomanometer. Thiswas similar in 
design to the IPC, described below, and a major 
departure from existing devices that compress only 
the arch of the foot. The second device, FCD4, is 
designed to wrap around the foot, using two Velcro 
straps to hold the device in place. Both devices used 
the same pump, modified from that used by the IPC 
device described below, with the duration of infla- 
tion set at S seconds, followed by a 20-second rest 
period. The pressure can be adjusted from 120 to 
220 mm Hg; the recommended setting of 155 mm 
Hg was used in this study. 
The Venodyne calfIPC device places an inflatable 
plastic sleeve over the entire calf, which is then in- 
flated to a pressure of 40 to 45 mm Hg for 12 
seconds, followed by a 48-second rest period. The 
pump automatically controls the inflation of the 
sleeve. The sleeve is 14 inches long and will fit some- 
one with a calf circumference upto 16.5 inches. 
M1 five devices were tested on each subject in a 
random fashion (on a single lower extremity). Du- 
plex-derived hemodynamic values were obtained 
during the compression cycle from the popliteal vein 
(PV) and the common femoral vein (CFV) of the 
right leg on all subjects. This was repeated three 
times for each device, with a short rest period be- 
tween each determination (as well as each device). 
The patients were resting comfortably in 1S-degree 
reverse-Trendelenburg position. All scanning was 
performed by a single registered vascular technolo- 
gist using a state-of-the-art diagnostic ultrasound 
system (Sonos 2000, Hewlett-Packard Corp., Burl- 
ington, Mass.). A 7.5 MHz transducer was used, and 
the Doppler angle was maintained at60 degrees. 
The following Doppler-derived values were re- 
corded: (1) resting (peak) systolic velocity (RSV)14; 
(2) maximum venous velocity (MVV) 14 during de- 
vice activation; (3) acceleration, the slope of the line 
from RSV to MVV (calculated by fixing a tangent 
line to the curve corresponding to the steepest lope); 
and (4) return time (RT), the time from MVV back to 
RSV. These values are illustrated in Fig. 1. 
All data are represented asthe mean _+ standard 
deviation. PV versus CFV values and RSV versus 
MVV values for individual devices were compared by 
Student's t test. All other analyses were performed 
with the analysis of variance (A_NOVA) with Bonfer- 
roni's test o confirm points of significance. A p value 
of 0.05 or less was considered significant. All statisti- 
cal analyses were done with Prism 2.01 statistical 
software (GraphPad Software, San Diego, Calif.). 
RESULTS 
All subjects howed normal gray:scale and color 
duplex venous patterns without evidence of prior 
thrombotic disease or insufficiency. The P, SV was 
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Fig. 1. Doppler-derived measurements. RSV, Resting (peak) systolic velocity; MVV, maxi- 
mum venous velocity, during device activation; AC, acceleration, the slope of the line from RSV 
to MVV; and RT, return time, the time from MW back to RSV. 
Table I. Comparison of  devices tested 
Device FCD1 FCD2 FCD3 FCD4 IPC 
Manufacturer Kendall Kinetic Conceptions Advanced Instruments Advanced Instruments Advanced Instruments 
Type of device Foot Foot Foot Foot Calf 
Compression method Arch Arch Entire foot Arch Entire calf 
Inflation time (see)* 3.75 2.0 5.0 5.0 12 
Cycles (per minute) 3 3 3 3 1 
Pressure (mm Hg)* 130 160 155 155 40 
*Settings used in this series of experiments, as recommended by manufacturer. A range of settings exists for each device. FCD 1 includes 
device "impulse time" and cuff "inflation time," as described by the manufacturer, as total time listed here. See text for explanation. 
higher in the CFV (24.3 + 6.7 cm/sec) than in the 
PV (12.5 + 3.7 cm/sec; t test, p < 0.0001). How- 
ever, the initial RSV was not statistically significant 
between the five experimental groups (ANOVA, p = 
0.37) at either the PV or CFV (Table II). 
The MVV increased significantly (by the 
ANOVA test) over the RSV for each device on an 
individual basis at the PV (p < 0.0001) and CFV 
(p < 0.001) levels. The MVV reached statistical sig- 
nificance with the FCD2 and IPC devices when all 
devices were Compared with each other (Table II; 
ANOVA, p = 0.0002; Bonferroni's test, p < 0.01). 
At the CFV, the differences were even less, indicating 
that the changes in velocity may dissipate as flow 
progresses proximally. 
The two commercially available foot devices, 
FCD1 and FCD2, demonstrated the greatest accel- 
eration at both the PV and CFV (Table II) compared 
with the other three devices, and this difference was 
statistically significant (ANOVA, p = 0.0001; Bon- 
ferroni's test, p < 0.01). 
The return to baseline velocity, RT, was signifi- 
cantly slower with the IPC than with any of the foot 
devices at both the PV and CFV (Table II; ANOVA, 
p = 0.0001; Bonferroni's test, p < 0.01). RT was 
four to 10 times slower at the PV and three to five 
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Table I I .  Venous hemodynamic values 
FCD 1 FCD 2 FCD 3 FCD4 IPC p * 
Pv 
RSV (cm/sec) 13.1 ± 4.6 11.2 _+ 2.8 12.4 ± 3.9 13.0 -- 3.6 12.7 _+ 3.5 0.36 
95% confidence interval 11.3-14.9 10.1-12.3 10.9-14.0 11.3-14.7 11.3-14.1 - -  
MW (cm/sec) 47.3 ± 16.8 55.2 _+ 15.5 42.6 ± 16.8 35.2 ± 16.3 55.3 +_ 19.5 0.0002 
95% confidence interval 40.6-53.9 49.1-61.3 36.0-49.2 27.6-42.9 47.6-63.0 - -  
Acceleration (cmZ/sec) 244 ± 135 269 _+ 118 156 _+ 113 81 ± 61 48 _+ 25 0.0001 
95% confidence interval 191-297 222-316 111-200 52-110 38-58 - -  
RT (see) 0.21 ± 0.06 0.23 ± 0.06 0.32 ± 0.08 0.47 ± 0.12 2.14 ± 0.65 0.0001 
95% confidence interval 0.18-0.23 0.21-0.26 0.29-0.35 0.41-0.53 1.9-2.4 - -  
CFV 
RSV (cm/sec) 24.8 _+ 5.5 24.5 ± 6.7 23.3 ± 6.9 25.9 _+ 7.6 23.6 ± 7.4 0.7i 
95% confidence interval 22.6-26.9 33.6-41.5 20.5-26.0 22.3-29.5 20.7-26.6 - -  
MVV (cm/sec) 35.8 ± 9.1 37.5 _+ 10.0 31.0 ± 7.7 33.5 ± 9.3 40.4 _+ 10.6 0.0053 
95% confidence interval 32.2-39.4 33.6-41.5 28.0-34.0 29.2-37.9 36.2-44.6 - -  
Acceleration (cmZ/sec) 101 ± 65 104 _+ 81 46 ± 29 43 _+ 28 41 ± 22 0.0001 
95% confidence interval 75-126 72-136 35-58 29-56 32-49 - -  
RT (see) 0.23 ± 0.12 0.22 _+ 0.10 0.29 ± 0.14 0.37 +_ 0.20 1.07 ± 0.52 0.0001 
95% confidence interval 0.19-0.28 0.19-0.26 0.23-0.34 0.28-0.47 0.86-1.27 --  
*Listed p value refers to results of ANOVA for each row. See text for details. 
times slower at the CFV when compared with the 
other four devices. 
DISCUSSION 
Both drugs and compression devices are effective 
in preventing venous thrombosis after surgery. How-  
ever, Shackford and coworkers 3 determined that one 
in seven high-risk trauma patients were not candi- 
dates for either method. One approach has been 
more frequent use of  vena caval filters, 15 whereas 
others have used new foot compressive devices such 
as those tested in this study. 6-9 As noted above, the 
foot has a unique venous system that forms the ratio- 
nale for use Of these devices. 1°-1~ Unfortunately, al- 
though these devices have obvious appeal, clinical 
experience is limited. It  was the intention of  this 
study to examine the effects o f  foot devices on venous 
hemodynamics when compared with a "convention- 
al" calf IPC device. 
Resting velocities obtained in this study at the 
popliteal and femoral levels were similar to those 
reported by Killewich et al.,14 who compared iffer- 
ent settings on a single foot device (FCD1). They, 
too, found that the RSV in the CFV was significantly 
higher than in the PV. 14 With activation of  the com- 
pression devices, the peak velocity o f  flow (MVV) 
increased with all devices, although it was greatest 
with one foot device (FCD2) and the calf IPC de- 
vice. Although Killewich et al. 14 found a significant 
increase in MVV compared with RSV with the A-V 
Impulse device (FCDI ) ,  as was seen with every de- 
vice in this study, when compared with other devices 
FCD1 did not produce a significant difference. The 
velocity recorded in the popliteal vein in this study 
was in between the velocities recorded by White et 
al. 12 in the posterior tibial veins (123 + 71 cm/sec)  
and the peroneal (29 _+ 26 cm/sec)  and anterior 
tibial (24 _+ 14 cm/sec)  veins, perhaps representing 
an "averaging" o f  these three systems within the 
popliteal vein. In addition, by the femoral level this 
increase in velocity was less prominent, although it 
remained significantly greater than the RSV for each 
device at that level, as well. 
Not  surprisingly, because of  their mechanism of  
action, the commercially available devices produced a
sharp peak in velocity with the greatest acceleration. 
Although the MVV of  two of  the devices (FCD2, 
IPC) was statistically significant at the PV compared 
with the FCD4 device only, this is o f  questionable 
clinical significance, especially because all devices 
produced a statistically significant increase in MVV 
compared with baseline (RSV) levels (Table II). 
Also, easily understandable on the basis o f  the oper- 
ating mechanism, the slowest return (presumably a 
positive factor because venous flow would be en- 
hanced longer) was seen with the IPC device. That 
device has a gradual inflation and thus the lowest 
acceleration with the slowest RT. One can estimate 
that blood is moving with the IPC device for the 
inflation period (12 seconds) plus an additional 1 to 
2 seconds during the RT (Table II). The foot de- 
vices, on the other hand, have a 1- to 2-second 
compression period with return times less than 0.5 
second. Although they typically activate three times 
per minute, based on this study, the total time that 
blood is moving in the venous system is less. 
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In reality, however, the clinical significance of  
these hemodynamic changes is unknown. Pneumatic 
compression devices may work, at least in part, by a 
systemic activation of  the fibrinolytic system.16,17 It  is 
not l~aown whether foot-only devices produce the 
same changes. Another mechanism of  action is pre- 
sumed to be through the hemodynamic alterations 
that avoid venous stasis. The necessary magnitude 
and duration of  these alterations is unknown. When 
more complex sequential devices are used, venous 
hemodynamics are more profoundly affected, 17 but 
there is no clinically important difference in their 
ability to prevent DVT compared with calf-only de- 
vices. 
What, then, is the significance of  the comparative 
changes in venous hcmodynamics seen in this study? 
Presumably, there is some minimal hemodynamic 
change that is clinically effective in stimulating fi- 
brinolytic activation and preventing stasis. The calf- 
only devices produce sufficient hemodynamic or fi- 
brinolytic changes because they have been shown to 
be clinically effective in preventing DVT)  ,2,4 The 
foot devices may produce sufficient changes as well, 
but the ultimate answer is determined by their clini- 
cal effectiveness. This study shows that the IPC de- 
vice produced longer RTs than the other devices, 
validating our hypothesis in part, but the MW 
among each device was similar and the acceleration 
with the foot-only devices was much higher. It is 
unknown which fac tor - -MW,  acceleration, or 
RT- -might  have the greatest importance in DVT 
prevention, whether all are equally important, or 
whether other, unmeasured factors are most signifi- 
cant. 
CONCLUSION 
On the basis o f  our data, it would seem that the 
commercially available foot devices produce a rapid 
impulse of  flow with a high MVV and acceleration, 
with a rapid return to baseline. FCD3 performs in a 
similar fashion. IPC,  on the other hand, produces a 
gradual increase in flow (slow acceleration) to a sim- 
ilar peak (MVV) with a slow return to baseline. O f  all 
the devices, however, it would seem that the foot- 
sleeve compression of  the experimental device, 
FCD4,  would be most suspect in our opinion, be- 
cause it has a moderate acceleration to a lower MW 
with a rapid return to baseline (RT). 
The major conclusion to be drawn from this 
study is that foot devices produce hemodynamic 
changes in venous flow that are not  equivalent o 
existing calf devices. However,  it must be stressed 
that the clinical significance of  this is unlmown. 
There remains a serious need for randomized, con- 
trolled comparative clinical trials, based on the inten- 
tion-to-treat principle because calf devices will not  be 
suitable for many injured patients. 3 Until such trials 
are carried out, if the devices are used in clinical 
situations, particularly in multitrauma patients, con- 
tinued awareness o f  the lack o f  clinical data must be 
kept in mind. 
All devices used in this study were loaned for the 
period of study by Advanced Instruments. 
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